Market Insights Health Medical Technology Medical Devices

Diagnostic Imaging Devices - North America

North America

The Diagnostic Imaging Devices market market in North America is expected to witness significant growth in the coming years.
According to projections, the revenue in this market is projected to reach a staggering US$13.91bn by 2024.
This growth is anticipated to continue, with an estimated annual growth rate of 3.82% from 2024 to 2029.
As a result, the market volume is expected to reach US$16.78bn by 2029.
In terms of global comparison, it is worth noting that the United States is expected to generate the highest revenue in the Diagnostic Imaging Devices market market in North AmeriIn 2024 alone, the United States is projected to generate approximately US$11,930.00m in revenue.
This highlights the dominance of the United States in this market within the North American region.
North America leads the way in the adoption of advanced diagnostic imaging devices, revolutionizing medical technology.

Key regions: Germany, Japan, Netherlands, Spain, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Diagnostic Imaging Devices market in North America is experiencing steady growth due to various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in North America play a significant role in the development of the Diagnostic Imaging Devices market. Customers in this region prioritize high-quality healthcare services and advanced medical technologies. They value accurate and timely diagnosis, which can be achieved through the use of diagnostic imaging devices. Additionally, customers in North America are increasingly seeking non-invasive diagnostic procedures, which further drives the demand for imaging devices. Trends in the market also contribute to the growth of the Diagnostic Imaging Devices market in North America. One notable trend is the increasing adoption of digital imaging technologies. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, enhanced image quality, and easier storage and retrieval of patient data. This trend is driven by the need for efficient and streamlined healthcare processes, as well as advancements in imaging technology. Another trend in the market is the integration of artificial intelligence (AI) in diagnostic imaging devices. AI algorithms can analyze medical images and assist healthcare professionals in making accurate diagnoses. This trend is driven by the growing availability of large datasets and advancements in machine learning algorithms. The integration of AI in diagnostic imaging devices improves efficiency, accuracy, and patient outcomes. Local special circumstances also contribute to the development of the Diagnostic Imaging Devices market in North America. The region has a well-established healthcare infrastructure and a high level of healthcare expenditure. This enables healthcare providers to invest in advanced medical technologies, including diagnostic imaging devices. Additionally, North America has a large aging population, which increases the demand for diagnostic imaging services. Underlying macroeconomic factors further support the growth of the Diagnostic Imaging Devices market in North America. The region has a stable and growing economy, which provides a favorable business environment for healthcare companies. Moreover, government initiatives and policies aimed at improving healthcare access and quality drive the demand for diagnostic imaging devices. In conclusion, the Diagnostic Imaging Devices market in North America is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The region's focus on high-quality healthcare services, the adoption of digital imaging technologies, the integration of AI in diagnostic imaging devices, a well-established healthcare infrastructure, a large aging population, and a stable economy all contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.